Marko Sinisa Stojic

Dr. Marko Sinisa Stojic

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2023 in Medicine
Verified
Journal Article
Open access
MPMiloš Pantelić
Miloš Pantelić
MSMarko Sinisa Stojic
Marko Sinisa Stojic
ĐPĐorđe Petrović
Đorđe Petrović
LMLjiljana Mladenović-Segedi
Ljiljana Mladenović-Segedi
BBBranislava Baturan
Branislava Baturan
BGBorislav Golijan
Borislav Golijan
Rationale: Necrotizing fasciitis is rapidly progressive infection with high mortality rate. This study aimed to summarize the clinical and pathological presentation of this case. Patient concerns: A 46-year-old woman patient presented to our emergency department of an obstetric and gynecology clinic on the 8th day after total abdominal hysterectomy. The abdominal wall showed pronounced signs of inflammation. Abundant purulent content was oozing from the abdominal wound. Diagnoses: The patient underwent surgery. Areas of necrosis were observed on the skin around the wound, the subcutaneous fatty tissue was necrotic around the incision site, and the fascia was completely dehisced. Interventions: Wound debridement and flap cutting of the anterior abdominal wall were performed. Metronidazole, ceftriaxone, and vancomycin were administered intravenously. A plastic surgeon suggested daily debridement and toileting of the wound in the operating room. Swabs of the abdominal cavity, abscess cavity, and abdominal wound were obtained, and Enterococcus faecalis was isolated. After the negativism of microbiological swabs, excochleation of granulation tissue was performed by a plastic surgeon. Outcomes: Nineteen days after the relaparotomy, the patient was discharged in good general condition with advice for further monitoring and therapy. Lessons: Successful treatment of necrotizing fasciitis can be achieved through an initial diagnosis, adequate debridement, empirical broad-spectrum antibiotic coverage, and multidisciplinary treatment.

1 January 2024 in Medicinski Pregled
Verified
Journal Article
Open access
PDF file
MSMarko Sinisa Stojic
Marko Sinisa Stojic
MPMilos Pantelic
Milos Pantelic
JUJovan Ugarkovic
Jovan Ugarkovic
GNGabriel-Stefan Nadj
Gabriel-Stefan Nadj
AIAleksandra Ilić
Aleksandra Ilić
Introduction. Vulvar carcinoma is a rare gynecological malignancy, accounting for 0.6 percent of all female cancers. Case Report. A-76-year-old woman presented with a tumorous lesion in the lower third of the left labia majora and minora, measuring approximately 25 mm. A multifocal biopsy was conducted, and pelvic magnetic resonance imaging revealed slight enlargement of a left inguinal solid lymph node. The patient underwent a left hemivulvectomy with inguinofemoral lymphadenectomy. Histopathological analysis confirmed a malignant lentiginous tumor, and inguinofemoral lymphadenectomy revealed metastatic malignant melanoma. Despite a negative histopathological finding of the contralateral side during the initial biopsy, the patient returned within three months with a 9-mm mucosal nodular type melanoma on the lower third of the right labia majora. A wide excision of the vulva was subsequently performed. Following consultation with a multidisciplinary tumor board, adjuvant immunotherapy with Pembrolizumab (200 mg per cycle, 9 cycles) was initiated. Conclusion. Vulvar malignant melanoma is rare, aggressive, and unpredictable tumor that predominantly affects women in later life. It is associated with a high recurrence rate and a poor overall prognosis.

1 January 2022 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
PDF file
MPMilos Pantelic
Milos Pantelic
MSMarko Sinisa Stojic
Marko Sinisa Stojic
ACAleksandar Curcic
Aleksandar Curcic
MDMiso Dukic
Miso Dukic
UKUros Kadic
Uros Kadic
MMMilos Maletin
Milos Maletin
Introduction/Objective. Stress urinary incontinence (SUI) is defined as the complaint of involuntary loss of urine in effort or physical exertion, or on sneezing or coughing. It is a common clinical condition affecting 50% of middle-aged and elderly women. Mid-urethral slings (MUSs) are the gold standard in the treatment of SUI. The aim of this study was to investigate the success rate and complications of surgical treatment of SUI in women with transobturator tape (TOT) within the three years of follow-up. Methods. From January 2011 until January 2018, 86 women with predominantly SUI were operated by TOT procedure. In 61.6% of patients SUI was confirmed by preoperative urodynamic examination (cystometry, uroflowmetry, urethral presser profile) and in 38.4% of patients by clinical examination of stress test (cough provocation). All patients were invited for a follow-up examination 6, 12, 24 and 36 months after surgery. The result of the operation is defined as cured, improved or without success. Results. The average age was 55 (32-72) years. The most common complications were tape erosion (3.5%), incision bleeding (2.3%), transient leg pain (3.5%), dyspareunia (2.3%), vaginal erosion (3.5%) and de novo urge (5.8%). After three years of follow-up, 82.6% patients were cured. Conclusion. TOT is a safe, effective and successful procedure with 82.6% of cured patients during a three-year follow-up.

3 July 2026 in Molecules
Verified
Journal Article
Open access
PDF file
DSDragan Stajić
Dragan Stajić
MBMirjana A. Bogavac
Mirjana A. Bogavac
MSMarko Sinisa Stojic
Marko Sinisa Stojic
GNGabriel-Stefan Nadj
Gabriel-Stefan Nadj
MIMarko Ilinčić
Marko Ilinčić
Jovana MiskovicJovana Miskovic
Jovana Miskovic
Pregnancy involves profound metabolic, hormonal, and immunological adaptations essential for fetal development; however, disturbances may lead to complications such as preeclampsia (PE), pre-gestational diabetes, and gestational diabetes mellitus (GDM). These conditions are closely linked to oxidative stress, inflammation, endothelial dysfunction, impaired placentation, and metabolic dysregulation. Consequently, dietary strategies capable of modulating these pathways are of increasing interest. Edible and medicinal mushrooms are widely studied as functional food due to the content of bioactive compounds with antioxidant, anti-inflammatory, immunomodulatory, and metabolic regulatory effects. This review summarizes the nutritional composition of mushrooms and highlights key bioactive constituents with antioxidant and metabolic regulatory properties. Among them, ergothioneine has emerged as a key molecule due to its potent redox-buffering capacity and its potential involvement in the activation of the Nrf2 signaling pathway, a master regulator of cellular antioxidant defense. Through modulation of Nrf2-dependent gene expression, mushroom-derived compounds may contribute to improved cellular resilience against oxidative damage relevant to PE and GDM pathophysiology. Mushroom consumption has additionally been associated with improved glycemic control and enhanced antioxidant defenses in experimental and limited clinical studies, although evidence regarding the prevention or management of hypertensive and metabolic pregnancy complications remains insufficient. Although preclinical findings are promising, clinical evidence remains limited. Further well-designed prospective studies and randomized controlled trials are required to determine efficacy, safety, optimal intake, and active compounds responsible for these effects. Nevertheless, current evidence supports the biological plausibility that edible and medicinal mushrooms are promising dietary modulators of the ergothioneine–Nrf2 axis with potential relevance for maternal–fetal health.

5 June 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
DSDragan Stajić
Dragan Stajić
MBMirjana A. Bogavac
Mirjana A. Bogavac
MSMarko Sinisa Stojic
Marko Sinisa Stojic
GNGabriel-Stefan Nadj
Gabriel-Stefan Nadj
MIMarko Ilinčić
Marko Ilinčić
Jovana MiskovicJovana Miskovic
Jovana Miskovic
Pregnancy involves profound metabolic, hormonal, and immunological adaptations essential for fetal development; however, disturbances may lead to complications such as preeclampsia (PE), pre-gestational diabetes, and gestational diabetes mellitus (GDM). These conditions are closely linked to oxidative stress, inflammation, endothelial dysfunction, impaired placentation, and metabolic dysregulation. Consequently, dietary strategies capable of modulating these pathways are of increasing interest. Edible and medicinal mushrooms have emerged as functional foods rich in bioactive compounds with antioxidant, anti-inflammatory, immunomodulatory, and metabolic regulatory effects. This review summarizes the nutritional composition of mushrooms and highlights key bioactive constituents, such as ergothioneine, which may influence redox balance, immune responses, glucose metabolism, endothelial function, and placental development. Experimental evidence suggests that these compounds modulate pathways involved in PE and GDM pathogenesis. Mushroom consumption has additionally been associated with improved glycemic control, enhanced antioxidant defenses, and reduced risk of hypertensive and metabolic pregnancy complications. Although preclinical findings are promising, clinical evidence remains limited. Further well-designed prospective studies and randomized controlled trials are required to determine efficacy, safety, optimal intake, and active compounds responsible for these effects. Nevertheless, current evidence supports edible and medicinal mushrooms as potential dietary modulators of key mechanisms involved in PE and GDM, with relevance for improving maternal-fetal health outcomes.